Float hits $15M in funding 

SAN FRANCISCO – Float, a provider of on-demand home infusion nurses, has announced $10 million in Series A funding led by Canvas Ventures, whose General Partner Mike Ghaffary has joined Float's board, with participation from Wave Capital, Y Combinator, Burst Capital, and Also Capital. With $15 million in total funding, Float now has the capital, talent, and technology to continue tackling a root cause of health care's most pressing issues: chronic illness. "After years in the emergency room treating patients with chronic conditions, and from treating my dad who suffers from one, I realized that moving specialty medicine into the home would be a sea change for everyone, " said Ryan Johnson, CEO of Float. "Expanding access to this type of care would have a huge impact on patient outcomes, not to mention the burnout of my nurse friends exhausted by long shifts and juggling priorities. Float has proven successful in doing exactly that." Several tech industry founders and leaders have joined as angels, including Max Mullen, co-founder of Instacart, Andrew Bartynski, vice president of strategy and operations at ASRI, Brian Pokorny, former general partner of SV Angel, Jed Nachman, COO of Yelp, and Brian Osborn, former vice president of marketing at Yelp. Founded in 2021 by former ER nurse Johnson and Christy Johnson, COO, Float has built a network of hundreds of nurses across California and Arizona. Ryan's experience in nursing, along with Christy's background in startups and operations, has allowed them to recognize the massive need to scale their service to expand access to specialty infusions. Float's customers are some of the biggest names in specialty medicine, such as Optum, CVS, Option Care, Alliance RX (Walgreen's), Kroger, Kabafusion, Soleo Health, NuFactor, Care Fusion, CA Specialty Pharmacy, and more.